These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35373127)

  • 1. Hepatorenal Syndrome Type 1: From Diagnosis Ascertainment to Goal-Oriented Pharmacologic Therapy.
    Velez JCQ
    Kidney360; 2022 Feb; 3(2):382-395. PubMed ID: 35373127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW
    Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL
    Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring Renal Function and Therapy of Hepatorenal Syndrome Patients with Cirrhosis.
    Juanola A; Solé C; Toapanta D; Ginès P; Solà E
    Clin Liver Dis; 2021 May; 25(2):441-460. PubMed ID: 33838860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
    Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P
    J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury in patients with cirrhosis: Acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting.
    Nadim MK; Kellum JA; Forni L; Francoz C; Asrani SK; Ostermann M; Allegretti AS; Neyra JA; Olson JC; Piano S; VanWagner LB; Verna EC; Akcan-Arikan A; Angeli P; Belcher JM; Biggins SW; Deep A; Garcia-Tsao G; Genyk YS; Gines P; Kamath PS; Kane-Gill SL; Kaushik M; Lumlertgul N; Macedo E; Maiwall R; Marciano S; Pichler RH; Ronco C; Tandon P; Velez JQ; Mehta RL; Durand F
    J Hepatol; 2024 Jul; 81(1):163-183. PubMed ID: 38527522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatorenal syndrome - update 2020].
    Krátká K; Libicherová P; Mejzlíková N; Rychlík I
    Vnitr Lek; 2020; 66(3):71-75. PubMed ID: 32972169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatorenal Syndrome in Cirrhosis.
    Pose E; Piano S; Juanola A; Ginès P
    Gastroenterology; 2024 Apr; 166(4):588-604.e1. PubMed ID: 38246506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatorenal Syndrome: Pathophysiology, Diagnosis, and Treatment.
    Belcher JM
    Med Clin North Am; 2023 Jul; 107(4):781-792. PubMed ID: 37258014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Pharmacologic Therapies for Hepatorenal Syndrome-Acute Kidney Injury.
    Duong N; Kakadiya P; Bajaj JS
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10S):S27-S34. PubMed ID: 37625864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Securing the diagnosis of HRS-AKI: implications for current therapies.
    Mohanty A; Cárdenas A
    Expert Rev Gastroenterol Hepatol; 2023 Dec; 17(12):1233-1239. PubMed ID: 37982156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Gupta K; Bhurwal A; Law C; Ventre S; Minacapelli CD; Kabaria S; Li Y; Tait C; Catalano C; Rustgi VK
    World J Gastroenterol; 2021 Jul; 27(26):3984-4003. PubMed ID: 34326609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatorenal syndrome.
    Ginès P; Solà E; Angeli P; Wong F; Nadim MK; Kamath PS
    Nat Rev Dis Primers; 2018 Sep; 4(1):23. PubMed ID: 30213943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.
    Olson JC; Subramanian RM
    PLoS One; 2024; 19(1):e0296690. PubMed ID: 38285703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Kidney Injury in Patients with Liver Disease.
    Cullaro G; Kanduri SR; Velez JCQ
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1674-1684. PubMed ID: 35902128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Current Management of Hepatorenal Syndrome-Acute Kidney Injury in the United States and the Potential of Terlipressin.
    Flamm SL; Brown K; Wadei HM; Brown RS; Kugelmas M; Samaniego-Picota M; Burra P; Poordad F; Saab S
    Liver Transpl; 2021 Aug; 27(8):1191-1202. PubMed ID: 33848394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatorenal syndrome in the era of acute kidney injury.
    Solé C; Pose E; Solà E; Ginès P
    Liver Int; 2018 Nov; 38(11):1891-1901. PubMed ID: 29845739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatorenal Syndrome-Acute Kidney Injury in Liver Transplantation.
    Lizaola-Mayo B; Vargas HE
    Clin Gastroenterol Hepatol; 2023 Sep; 21(10S):S20-S26. PubMed ID: 37625863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrated Review of the Hepatorenal Syndrome.
    Ojeda-Yuren AS; Cerda-Reyes E; Herrero-Maceda MR; Castro-Narro G; Piano S
    Ann Hepatol; 2021; 22():100236. PubMed ID: 32846202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.